CareDx Inc (CDNA)
CareDx together with its subsidiaries, is a medicine company focused on the discovery, development and commercialization of diagnostic solutions for transplant patients and caregivers. Co. provides testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey, and is a provider of genomics-based information for transplant patients. Co.'s commercially available testing services consist of AlloSure® Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients, AlloMap® Heart, a solution for heart transplant patients, AlloSure® Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure® Lung.
CDNA SEC Filing Email Alerts Service
| Company Name: |
CareDx Inc |
| Website: |
www.caredx.com |
| Sector: |
Diagnostics |
| Number of ETFs Holding CDNA: |
21 |
| Total Market Value Held by ETFs: |
$113.31M |
| Total Market Capitalization: |
$428.00M |
| % of Market Cap. Held by ETFs: |
26.47% |
|
|
April 27, 2024 • 12:10 AM Eastern
Buy (3.00 out of 4)
31st percentile
|
|
Free CDNA Email Alerts:
